Boston, USA-based Ratio Therapeutics has raised $50 million in a series B financing, bringing the total raised by the company so far to over $90 million. 18 January 2024
Two new initial public offerings (IPO) are set to go ahead in the USA, raising hopes of a thaw in what has been a long winter for biotech companies going public 17 January 2024
Washington University in Missouri, USA, has joined forces with the life sciences investment company Deerfield Management to launch a new R&D venture. 17 January 2024
Switzerland-based Stalicla, a biopharma advancing precision medicine pipelines for neuropsychiatric and neurological disorders, has announced the successful com 16 January 2024
Arena BioWorks has announced its launch as a biomedical research institute with a mission to uncover mechanisms of disease by engaging in basic biological resea 15 January 2024
Massachusetts, USA-based Dyne Therapeutics has raised $345 million, shortly after announcing encouraging biomarker data for its Duchenne muscular dystrophy (DMD 15 January 2024
A major equity investment will see Germany’s Bayer and New York-based life science investor RTW Investments take a stake in a Chinese biotech working on heart a 11 January 2024
Singapore-based Novotech, an Asia-Pacific-focused contract research organization (CRO), has presented research on financial shifts in the biotech industry in 20 29 December 2023
Tonix Pharmaceuticals Holding Corp has announced highly statistically significant and clinically meaningful topline results in a second positive Phase III trial 21 December 2023
Sign up to receive email updates Join industry leaders for a daily roundup of biotech & pharma news
Company Spotlight
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.